Rab7 induces clearance of α-synuclein aggregates. 2016

Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
Department of Neurology, RWTH University Aachen, Aachen, Germany.

Parkinson's disease can be caused by mutations in the α-synuclein gene and is characterized by aggregates of α-synuclein protein. Aggregates are degraded by the autophago-lysosomal pathway. Since Rab7 has been shown to regulate trafficking of late endosomes and autophagosomes, we hypothesized that over-expressing Rab7 might be beneficial in Parkinson's disease. To test this hypothesis, we expressed the pathogenic A53T mutant of α-synuclein in HEK293 cells and Drosophila melanogaster. In HEK293 cells, EGFP-Rab7-decorated vesicles contain α-synuclein. Rab7 over-expression reduced the percentage of cells with α-synuclein particles and the amount of α-synuclein protein. Time-lapse microscopy confirmed that particles frequently disappeared with Rab7 over-expression. Clearance of α-synuclein is explained by the increased occurrence of acidified α-synuclein vesicles with Rab7 over-expression, presumably representing autolysosomes. Rab7 over-expression reduced apoptosis and the percentage of dead cells in trypan blue staining. In the fly model, Rab7 rescued the locomotor deficit induced by neuronal expression of A53T-α-synuclein. These beneficial effects were not produced by Rab7 missense mutations causing Charcot Marie Tooth neuropathy, or by the related GTPases Rab5, Rab9, or Rab23. Using mass spectrometry, we identified Rab7 in neuromelanin granules purified from human substantia nigra, indicating that Rab7 might be involved in the biogenesis of these possibly protective, autophagosome-like organelles in dopaminergic neurons. Taken together, Rab7 increased the clearance of α-synuclein aggregates, reduced cell death, and rescued the phenotype in a fly model of Parkinson's disease. These findings indicate that Rab7 is rate-limiting for aggregate clearance, and that Rab7 activation may offer a therapeutic strategy for Parkinson's disease. Cells over-expressing aggregation-prone A53T alpha-synuclein develop cytoplasmic aggregates mimicking changes observed in Parkinson's disease. When following cells in time-lapse microscopy, some few cells are able to remove these aggregates (Opazo et al. 2008). We now show that the percentage of cells clearing all aggregates from their cytosol is greatly increased with Rab7 over-expression, indicating that availability of Rab7 is rate-limiting for autophagic clearance of aggregates. The functional significance of this effect in neurons was confirmed in a Drosophila melanogaster model of Parkinson's disease.

UI MeSH Term Description Entries
D008543 Melanins Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration. Allomelanins,Melanin,Phaeomelanins
D010588 Phagosomes Membrane-bound cytoplasmic vesicles formed by invagination of phagocytized material. They fuse with lysosomes to form phagolysosomes in which the hydrolytic enzymes of the lysosome digest the phagocytized material. Phagolysosomes,Phagolysosome,Phagosome
D004331 Drosophila melanogaster A species of fruit fly frequently used in genetics because of the large size of its chromosomes. D. melanogaster,Drosophila melanogasters,melanogaster, Drosophila
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090802 rab7 GTP-Binding Proteins A small family of rab GTP-binding proteins that play a key role in membrane trafficking in the late endocytic and autophagic pathways. Rab7 Proteins,ras-Related Protein Rab-7,GTP-Binding Proteins, rab7,Protein Rab-7, ras-Related,Proteins, Rab7,Proteins, rab7 GTP-Binding,Rab-7, ras-Related Protein,rab7 GTP Binding Proteins,ras Related Protein Rab 7
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D051844 alpha-Synuclein A synuclein that is a major component of LEWY BODIES and plays a role in SYNUCLEINOPATHIES, neurodegeneration and neuroprotection. Non-AB Component of AD Amyloid Protein,Non AB Component of AD Amyloid Protein,alpha Synuclein
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell

Related Publications

Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
May 2013, Neurotoxicity research,
Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
July 2014, Cell death and differentiation,
Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
March 2021, Chemphyschem : a European journal of chemical physics and physical chemistry,
Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
October 2019, Cellular and molecular neurobiology,
Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
January 2022, Experimental neurology,
Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
January 2022, PloS one,
Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
May 2016, Movement disorders : official journal of the Movement Disorder Society,
Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
January 2012, Methods in molecular biology (Clifton, N.J.),
Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
April 2012, Rejuvenation research,
Elisabeth Dinter, and Theodora Saridaki, and Markus Nippold, and Sarah Plum, and Leonie Diederichs, and Daniel Komnig, and Luisa Fensky, and Caroline May, and Katrin Marcus, and Aaron Voigt, and Jörg B Schulz, and Björn H Falkenburger
September 2019, Biochimica et biophysica acta. Proteins and proteomics,
Copied contents to your clipboard!